Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 21, 2018

Study Completion Date

December 21, 2018

Conditions
Patients With High-risk Prostate Cancer
Trial Locations (3)

15706

Hospital Universitario de Santiago de Compostela, Santiago de Compostela

28006

Hospital Universitario de La Princesa, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

All Listed Sponsors
lead

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER

NCT01800058 - Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy | Biotech Hunter | Biotech Hunter